{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T11:16:11Z","timestamp":1759058171184},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T00:00:00Z","timestamp":1516233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1038\/s41429-017-0002-2","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T06:29:17Z","timestamp":1516256957000},"page":"363-371","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["In vitro and in vivo antimicrobial activity of TS2037, a novel aminoglycoside antibiotic"],"prefix":"10.1038","volume":"71","author":[{"given":"Yoko","family":"Hirai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Maebashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Hiraiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuto","family":"Minowa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daishiro","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,18]]},"reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/1469-0691.12691","volume":"20","author":"S Tokajian","year":"2014","unstructured":"Tokajian S. New epidemiology of Staphylococcus aureus infections in the Middle East. Clin Microbiol Infect. 2014;20:624\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/1469-0691.12705","volume":"20","author":"CJ Chen","year":"2014","unstructured":"Chen CJ, Huang YC. New epidemiology of Staphylococcus aureus infection in Asia. Clin Microbiol Infect. 2014;20:605\u201323.","journal-title":"Clin Microbiol Infect"},{"key":"2_CR3","first-page":"479048","volume":"2014","author":"Y Sharma","year":"2014","unstructured":"Sharma Y, Jain S, Singh H, Govil V. Staphylococcus aureus: Screening for nasal carriers in a community setting with special reference to MRSA. Science. 2014;2014:479048.","journal-title":"Science"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/1471-2180-11-215","volume":"11","author":"GW Coombs","year":"2011","unstructured":"Coombs GW, Monecke S, Pearson JC, Tan HL, Chew YK, et al. Evolution and diversity of community-associated methicillin-resistant Staphylococcus aureus in a geographical region. BMC Microbiol. 2011;11:215.","journal-title":"BMC Microbiol"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/1469-0691.12159","volume":"19","author":"P Cocchi","year":"2013","unstructured":"Cocchi P, Taccetti G, Montagnani C, Campana S, Galli L, et al. Evidence of transmission of a Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus clone: a family affair. Clin Microbiol Infect. 2013;19:1158\u201362.","journal-title":"Clin Microbiol Infect"},{"key":"2_CR6","first-page":"DC12","volume":"8","author":"V Shetty","year":"2014","unstructured":"Shetty V, Trumbull K, Hegde A, Shenoy V, Prabhu R, et al. Prevalence of community-acquired methicillin-resistant Staphylococcus aureus nasal colonization among children. J Clin Diagn Res. 2014;8:DC12\u20135.","journal-title":"J Clin Diagn Res"},{"key":"2_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-7-51","volume":"7","author":"WT Lo","year":"2007","unstructured":"Lo WT, Lin WJ, Tseng MH, Lu JJ, Lee SY, et al. Nasal carriage of a single clone of community-acquired methicillin-resistant Staphylococcus aureus among kindergarten attendees in Northern Taiwan. BMC Infect Dis. 2007;7:51.","journal-title":"BMC Infect Dis"},{"key":"2_CR8","first-page":"12","volume":"65","author":"Z Ali","year":"2015","unstructured":"Ali Z, Mumtaz N, Naz SA, Jabeen N, Shafique M. Multi-drug resistant Pseudomonas aeruginosa: a threat of nosocomial infections in tertiary care hospitals. J Pak Med Assoc. 2015;65:12\u20136.","journal-title":"J Pak Med Assoc"},{"key":"2_CR9","first-page":"195","volume":"15","author":"AC Rodrigues","year":"2011","unstructured":"Rodrigues AC, Chang MR, N\u00f3brega GD, Rodrigues MS, Carvalho NC, et al. Metallo-\u03b2-lactamase and genetic diversity of Pseudomonas aeruginosa in intensive care units in Campo Grande, MS, Brazil. Braz J Infect Dis. 2011;15:195\u20139.","journal-title":"Braz J Infect Dis"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1099\/jmm.0.000421","volume":"66","author":"JA Karlowsky","year":"2017","unstructured":"Karlowsky JA, Hoban DJ, Hackel MA, Lob SH, Sahm DF. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015. J Med Microbiol. 2017;66:61\u20139.","journal-title":"J Med Microbiol"},{"key":"2_CR11","first-page":"7","volume":"30","author":"JR Mediavilla","year":"2016","unstructured":"Mediavilla JR, Patrawalla A, Chen L, Chavda KD, Mathema B, et al. Colistin- and carbapenem-resistant Escherichia coli harboring mcr-1 and blaNDM-5, causing a complicated urinary tract infection in a patient from the United States. MBio. 2016;30:7.","journal-title":"MBio"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"6369","DOI":"10.1016\/j.bmcl.2007.08.059","volume":"17","author":"Y Hiraiwa","year":"2007","unstructured":"Hiraiwa Y, Minowa N, Usui T, Akiyama Y, Maebashi K, et al. Effect of varying the 4\u201d-position of arbekacin derivatives on antibacterial activity against MRSA and Pseudomonas aeruginosa. Bioorg Med Chem Lett. 2007;17:6369\u201372.","journal-title":"Bioorg Med Chem Lett"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1128\/AAC.44.9.2242-2246.2000","volume":"44","author":"N Masuda","year":"2000","unstructured":"Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, et al. Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2000;44:2242\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"2_CR14","unstructured":"Performance standards for antimicrobial susceptibility testing; Twenty-second informational supplement. Clinical and Laboratory Standards Institute. 2012;M100-S22."},{"key":"2_CR15","doi-asserted-by":"publisher","unstructured":"Takahashi Y, Umemura E, Kobayashi Y, Murakami S, Nawa T et al. Discovery of 2-hydroxyarbekacin, a new aminoglycoside antibiotic with reduced nephrotoxicity. J Antibiot 2017;1\u20133. \n                    https:\/\/doi.org\/10.1038\/ja.2017.60\n                    \n                  .","DOI":"10.1038\/ja.2017.60"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.7164\/antibiotics.26.412","volume":"26","author":"S Kondo","year":"1973","unstructured":"Kondo S, Iinuma K, Yamamoto H. Syntheses of 1-N-(S)-4-amino-2-hydroxybutyryl)-kanamycin B and -3\u2032, 4\u2032-dideoxykanamycin B active against kanamycin-resistant bacteria. J Antibiot. 1973;26:412\u20135.","journal-title":"J Antibiot"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1016\/j.bmcl.2007.04.065","volume":"17","author":"Y Hiraiwa","year":"2007","unstructured":"Hiraiwa Y, Usui T, Akiyama Y, Maebashi K, Minowa N. Synthesis and antibacterial activity of 5-deoxy-5-episubstituted arbekacin derivatives. Bioorg Med Chem Lett. 2007;17:3540\u20133.","journal-title":"Bioorg Med Chem Lett"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1021\/cr0301088","volume":"105","author":"S Magnet","year":"2005","unstructured":"Magnet S, Blanchard JS. Molecular insights into aminoglycoside action and resistance. Chem Rev. 2005;105:477\u201398.","journal-title":"Chem Rev"},{"key":"2_CR19","first-page":"85","volume":"68","author":"H Goto","year":"2015","unstructured":"Goto H, Iwasaki M. Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibacterial agents. Jpn J Antibiot. 2015;68:85\u2013104. (2010)","journal-title":"Jpn J Antibiot"},{"key":"2_CR20","first-page":"139","volume":"6","author":"T Matsumoto","year":"2014","unstructured":"Matsumoto T. Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens. Clin Pharmacol. 2014;6:139\u201348.","journal-title":"Clin Pharmacol"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"5726","DOI":"10.1021\/acs.biochem.6b00770","volume":"55","author":"SY Holbrook","year":"2016","unstructured":"Holbrook SY, Garneau-Tsodikova S. Expanding aminoglycoside resistance enzyme regiospecificity by mutation and truncation. Biochemistry. 2016;55:5726\u201337.","journal-title":"Biochemistry"},{"key":"2_CR22","first-page":"36","volume":"56","author":"M Tabata","year":"2003","unstructured":"Tabata M, Shimizu M, Araake M, Ogawa H. Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA). Jpn J Antibiot. 2003;56:36\u201343.","journal-title":"Jpn J Antibiot"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1128\/AAC.49.4.1639-1641.2005","volume":"49","author":"P Keith","year":"2005","unstructured":"Keith P. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2005;49:479\u201387.","journal-title":"Antimicrob Agents Chemother"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"5874","DOI":"10.1128\/AAC.00624-11","volume":"55","author":"RT Cass","year":"2011","unstructured":"Cass RT, Brooks CD, Havrilla NA, Tack KJ, Borin MT, et al. Pharmacokinetics and safety of single and multiple doses of ACHN-490 injection administered intravenously in healthy subjects. Antimicrob Agents Chemother. 2011;55:5874\u201380.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41429-017-0002-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-017-0002-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-017-0002-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:30:35Z","timestamp":1684618235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-017-0002-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,18]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["2"],"URL":"https:\/\/doi.org\/10.1038\/s41429-017-0002-2","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,18]]},"assertion":[{"value":"19 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}